Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Jane M. Grant-Kels MD, FAAD Advisory Board

Robert T. Brodell MD, FAAD Editor-in-Chief

See All Experts

featured

Published in Dermatology

Journal Scan / Research · August 25, 2022

Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis

JAMA Dermatology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Sarah Chamlin MD

JAMA Dermatology

Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis: Long-term Results From the Daily Practice BioDay Registry

JAMA Dermatol 2022 Aug 10;[EPub Ahead of Print], LS Spekhorst, M de Graaf, NPA Zuithoff, JMPA van den Reek, M Kamsteeg, CM Boesjes, GLE Romeijn, L Loman, I Haeck, AJ Oosting, A de Boer-Brand, WRH Touwslager, A Flinterman, AMT van Lynden-van Nes, AH Gostynski, MS de Bruin-Weller, ML Schuttelaar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis

Additional Info

Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis: Long-term Results From the Daily Practice BioDay Registry

Further Reading

Rebound Growth of Infantile Hemangiomas After Discontinuation of Treatment With Propranolol vs Atenolol

Eliminating Wound Tension in an Edematous Lower-Extremity Defect Through Elastic Wrapping During Mohs Micrographic Surgery

Efficacy of Treatment With Isobutylamido Thiazolyl Resorcinol in Patients With Hyperpigmentation

Impact of AJCC Eighth Edition Staging Changes on Sentinel Lymph Node Biopsy Practices Among Patients With Melanoma

Outcomes of Using Wound Closure Techniques After Wide Excision of Hidradenitis Suppurativa Lesions

Allergic Contact Cheilitis/Stomatitis Owing to Beverages and Food

Assessing Skin Cancer Diagnosis Accuracy by Lesion Type, Physician Experience, and Examination Method

Doxycycline Post-Exposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention

Association Between 5α-Reductase Inhibitor Use for Dermatologic Conditions and the Risk of Breast or Gynecologic Cancers

Efficacy of Treatment With Secukinumab in Patients With Hidradenitis Suppurativa

Local Recurrence, Metastasis, and Mortality Rates Among Patients With Thin and In Situ Melanomas

Recently Updated